Meine wissenschaftliche Publikationen

Rokavec M, Justenhoven C, Schroth W, Istrate MA, Vollmert C, Illig T, Hamann U, Ko YD, Glavac D, Brauch H. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal risk. Clinical Cancer Research, 2007 Dec 15, 13(24):7506-14.

Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovic D, Schürer SC, Xu J, Wagoner G, Drew PD, Griffin PR, Burris TP. Supression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011 Apr 28;472(7344):491-4.

Zhang J, Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, Pascal BD, Garcia-Ordonez RD, Bruning JB, Istrate MA, Kojetin DJ, Dodge JA, Burris TP, Griffin PR. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Structural & Molecular Biology 2011 May;18(5):556-63.

Busby SA, Kumar N, Kuruvilla DS, Istrate MA, Conkright JJ, Wang Y, Kamenecka TM, Cameron MD, Roush WR, Burris TP, Griffin PR. Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors. ACS Chemical Biology, 2011 Jun 17;6(6):618-27.

Istrate MA, Spicer TP, Wang Y, Bernard JA, Helvering LM, Bocchinfuso WP, Richardson TI, Zink R, Kumar N, Cardona G, Montrose-Rafizadeh C, Dodge JA, Hodder P, Griffin PR. Development of an HTS compatible assay for discovery of RORα modulators using AlphaScreen® technology. Journal of Biomolecular Screening, 2011 Feb; 16(2):183-91.

Wang Y, Kumar N, Nuhant P, Cameron MD, Istrate MA, Roush WR, Griffin PR, Burris TP. Identification of SR1078, a Synthetic Agonist for the Orphan Nuclear Receptors RORα and RORγ. ACS Chemical Biology, Aug 30, 2010.

Istrate MA, Nussler AK, Eichelbaum M, Burk O. Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding. Biochemical and Biophysical Research Communications, 2010 Mar 19; 393(4):688-93.